Clinical Trial Update: A Study of LY3090106 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for LY3090106 in healthy participants and rheumatoid arthritis patients, sponsored by Eli Lilly, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• LY3090106

Snippet

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 1 | Status: COMPLETED